Core Takeaways – Highway To Health
In this snippet from the Highway to Health podcast, Luke Johnson, Co-Founder and CEO of CapExpert, shares a vital lesson learned from leading his venture: the power of a supportive, talented team. Drawing a parallel to his quarterback days, Johnson emphasizes the importance of surrounding oneself with individuals who are skilled and aligned with the…
Latest
Core Takeaways - Highway To Health
Technology’s Role in Revolutionizing Treatment in Healthcare
Dr. Scott Sigman, M.D., host of The Ortho Show, highlights the impending technological advancements in healthcare, emphasizing how it will enhance patient care and revolutionize surgical procedures. Dr. Sigman mentions the integration of ChatGPT in the operating room through CaliberAI, an AI company aiming to guide surgical interventions. Furthermore, Dr. Sigman shares his experience with…
Core Takeaways - Highway To Health
The Lifelong Impact of Athletic Training on Kids
Blair Bundy, the Director of Player Health for the Milwaukee Brewers, recently shared his insights on the importance of nurturing lifelong athletes from a young age. He emphasized that the ultimate goal for children participating in sports is not just about winning games but about fostering physical and mental resilience. Such individuals lessen the strain…
Core Takeaways - Highway To Health
Looking Beyond Profit to Harness Technology and Influence for Purpose in Healthcare
In the constantly changing landscape of technology and innovation, leveraging one’s resources for a purpose in healthcare beyond profit is becoming increasingly vital. Particularly in sectors like healthcare, the responsibility to contribute doesn’t merely revolve around monetary gains but is deeply rooted in purpose and influence. Harnessing the power of technology, intellectual property, and human…
Core Takeaways - Highway To Health
Health Literacy and the Consumerization of Healthcare
In a recent episode of the Highway to Health podcast discussing health literacy and the consumerization of healthcare, Dr. Chase Feiger, M.D., and CEO at Ostro emphasized the need for simplifying healthcare. Healthcare should be as user-friendly as platforms like Netflix or Amazon. The underlying message: without good health, everything else is inconsequential.
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
